Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
In this review, the new class of antihyperglycaemic agents with incretin effect, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dipeptidyl peptidase-4 inhibitors (IDPP-4), and novel sodium-glucose cotransporter 2 inhibitors (ISGLT2) that increase renal glucose excretion will be analyzed
Helicobacter pylori infection-A risk factor for lipid peroxidation and superoxide dismutase over-activity: A cross-sectional study among patients with dyspepsia in Cameroon
Q10 L-Q10
As GLP-1 medications continue to be prescribed to millions of people worldwide, more data will accumulate on the incidence, risk factors, mechanisms, and optimal management of this side effect
US$ 26.80
US$ 22.04
US$ 26.02
US$ 27.65
US$ 27.90
US$ 27.45
US$ 21.11
US$ 23.11
US$ 27.84
